21 October 2020>: Database Analysis
The Prognostic Role of Glutathione Peroxidase 1 and Immune Infiltrates in Glioma Investigated Using Public Datasets
Shigang Lv 12ABCDE* , Haitao Luo 13ABCD* , Kai Huang 12DEFG* , Xingen Zhu 12ABCEFG*DOI: 10.12659/MSM.926440
Med Sci Monit 2020; 26:e926440
Table 1 Correlation analysis between GPX1 and gene markers of immune cells in TIMER.
Description | Gene markers | GBM | LGG | ||||||
---|---|---|---|---|---|---|---|---|---|
None | Purity | None | Purity | ||||||
Cor | P | Cor | P | Cor | P | Cor | P | ||
CD8+ T cell | CD8A | 0.225 | * | 0.151 | 0.079 | 0.126 | * | 0.03 | 0.514 |
CD8B | 0.388 | *** | 0.307 | ** | 0.158 | ** | 0.068 | 0.137 | |
T cell (general) | CD3D | 0.563 | *** | 0.461 | *** | 0.453 | *** | 0.406 | *** |
CD3E | 0.408 | *** | 0.287 | ** | 0.459 | *** | 0.436 | *** | |
CD2 | 0.501 | *** | 0.38 | *** | 0.434 | *** | 0.41 | *** | |
B cell | CD19 | 0.187 | * | 0.17 | 0.047 | 0.416 | *** | 0.376 | *** |
CD79A | 0.164 | * | 0.16 | 0.062 | 0.374 | *** | 0.397 | *** | |
Monocyte | CD86 | 0.475 | *** | 0.392 | *** | 0.779 | *** | 0.754 | *** |
CCR2 | 0.377 | *** | 0.313 | ** | 0.413 | *** | 0.394 | *** | |
CD14 | 0.528 | *** | 0.357 | *** | 0.722 | *** | 0.708 | *** | |
TAM | CCL2 | 0.372 | *** | 0.183 | 0.032 | 0.46 | *** | 0.423 | *** |
CD68 | 0.514 | *** | 0.339 | *** | 0.809 | *** | 0.794 | *** | |
IL10 | 0.616 | *** | 0.438 | *** | 0.515 | *** | 0.469 | *** | |
M1 Macrophage | CCL5 | 0.473 | *** | 0.355 | *** | 0.476 | *** | 0.453 | *** |
IRF5 | 0.387 | *** | 0.175 | 0.040 | 0.769 | *** | 0.745 | *** | |
IL18 | 0.706 | *** | 0.573 | *** | 0.823 | *** | 0.806 | *** | |
M2 Macrophage | CD163 | 0.374 | *** | 0.204 | 0.017 | 0.526 | *** | 0.527 | *** |
VSIG4 | 0.671 | *** | 0.544 | *** | 0.717 | *** | 0.694 | *** | |
MS4A4A | 0.614 | *** | 0.472 | *** | 0.673 | *** | 0.67 | *** | |
Neutrophils | CD66b (CEACM8) | −0.23 | * | −0.296 | ** | −0.004 | 0.92 | −0.012 | 0.791 |
CD11b (ITGAM) | 0.304 | ** | 0.063 | 0.464 | 0.687 | 0.645 | *** | ||
CCR7 | 0.305 | ** | 0.214 | 0.011 | 0.274 | 0.26 | *** | ||
Natural killer cell | NCR3 | 0.308 | * | 0.238 | 0.005 | 0.198 | 0.184 | ** | |
CD127 | 0.291 | * | 0.132 | 0.124 | 0.234 | 0.192 | *** | ||
KIR2DL1 | 0.089 | 0.273 | 0.043 | 0.618 | −0.021 | 0.633 | 0.004 | 0.923 | |
Dendritic cell | HLA-DPB1 | 0.521 | *** | 0.386 | *** | 0.677 | *** | 0.653 | *** |
HLA-DRA | 0.64 | *** | 0.527 | *** | 0.666 | *** | 0.642 | *** | |
HLA-DPA1 | 0.478 | *** | 0.362 | *** | 0.617 | *** | 0.591 | *** | |
BDCA-1(CD1C) | 0.361 | *** | 0.191 | 0.025 | 0.339 | *** | 0.328 | *** | |
Th1 | CD4 | 0.436 | *** | 0.242 | * | 0.754 | *** | 0.727 | *** |
CD103 | 0.34 | *** | 0.413 | *** | 0.147 | ** | 0.168 | ** | |
TNF-α(TNF) | 0.266 | ** | 0.118 | 0.169 | 0.231 | *** | 0.181 | *** | |
Th2 | CD14 | 0.528 | *** | 0.357 | *** | 0.722 | *** | 0.708 | *** |
IL13 | −0.243 | 0.025 | −0.209 | 0.014 | 0.045 | 0.303 | 0.048 | 0.291 | |
Tfh | BCL6 | −0.355 | *** | −0.405 | *** | 0.145 | ** | 0.176 | ** |
IL21 | −0.014 | 0.868 | 0.021 | 0.807 | 0.095 | 0.031 | 0.073 | 0.113 | |
Th17 | STAT3 | −0.361 | *** | −0.371 | *** | 0.328 | *** | 0.332 | *** |
IL17A | −0.058 | 0.476 | −0.146 | 0.089 | −0.025 | 0.578 | −0.042 | 0.365 | |
Treg | CD103 | 0.34 | *** | 0.413 | *** | 0.147 | ** | 0.168 | ** |
CCR8 | 0.254 | * | 0.177 | 0.039 | 0.162 | ** | 0.166 | ** | |
STAT5B | −0.606 | *** | −0.525 | *** | −0.185 | *** | −0.127 | * | |
T cell exhaustion | PD-1(PDCD1) | 0.284 | ** | 0.216 | 0.011 | 0.538 | *** | 0.522 | *** |
TIM-3 (HAVCR2) | 0.62 | *** | 0.479 | *** | 0.805 | *** | 0.788 | *** | |
GZMB | 0.369 | *** | 0.237 | * | 0.182 | *** | 0.202 | *** | |
TIMER – Tumor Immune Estimation Resource; TAM – tumor-associated macrophage; Th – T helper cell; Tfh – follicular helper T cell; Treg – regulatory T cell; Cor – R value of Spearman’s correlation; None – correlation without adjustment; Purity – correlation adjusted by purity. * ** *** |